Author Affiliations11 Institute of Clinical and Experimental Lymphology of SB RAMS; E.N. Meshalkin Novisibirsk Institute of Circulation Pathology of Minzdrav of Russia
21 Institute of Clinical and Experimental Lymphology of SB RAMS; E.N. Meshalkin Novisibirsk Institute of Circulation Pathology of Minzdrav of Russia
31 Institute of Clinical and Experimental Lymphology of SB RAMS; E.N. Meshalkin Novisibirsk Institute of Circulation Pathology of Minzdrav of Russia
41 Institute of Clinical and Experimental Lymphology of SB RAMS; E.N. Meshalkin Novisibirsk Institute of Circulation Pathology of Minzdrav of Russia
51 Institute of Clinical and Experimental Lymphology of SB RAMS; E.N. Meshalkin Novisibirsk Institute of Circulation Pathology of Minzdrav of Russia
61 Institute of Clinical and Experimental Lymphology of SB RAMS
7E.N. Meshalkin Novisibirsk Institute of Circulation Pathology of Minzdrav of Russia
8E.N. Meshalkin Novisibirsk Institute of Circulation Pathology of Minzdrav of Russia
91 Institute of Clinical and Experimental Lymphology of SB RAMS; E.N. Meshalkin Novisibirsk Institute of Circulation Pathology of Minzdrav of Russia
1. Amtchislavskiy E.I., Sokolov D.I., Selkov S.A., Freidlin I.S. Proliferative activity of human endothelial cell line EA.Hy926 and it modulation // Tsitologiya. 2005. (5). 389–399. (in Russian)
2. Zakharov Yu.M. Cytoprotective effects of erythropoietin // Klinicheskaya nefrologiya. 2009. (1). 16–21. (in Russian)
3. Konenkov V.I., Poveschenko O.V., Kim I.I. Effect on G-CSF on proangiogenic properties mobilized peripheral blood cells in patients with chronic heart failure // Kletochnaya transplantologiya i tkanevaya inzheneriya. 2011. (3). 71–76. (in Russian)
4. Konenkov V.I., Pokuchalov E.A., Poveschenko O.V. et al. Characteristic of phenotype mobilized by granulocyte colony stimulating factor peripheral blood cells in patients with chronic heart failure // Kletochnye tekhnologii v biologii i meditsine. 2012. (1). 9–14. (in Russian)
5. Poveschenko O.V., Poveschenko A.F., Konenkov V.I. Physiological and cytological bases of cellular regulation of angiogenesis // Uspekhi sovremennoy biologii. 2012. (3).48–61. (in Russian)
6. Starikova E.A., Amtchislavskiy E.I., Sokolov D.I et al. Change of surface phenotype of endothelial cells under influence pro-inflammatory and anti-inflammatory cytokines // Meditsinskaya immunologya. 2003. (1–2). 39–48. (in Russian)
7. Atienza J.M., Yu N., Wang X. et al. Label-free and real-time cell-based kinase assay for screening selective and potent receptor tyrosine kinase inhibitors using microelectronic sensor array // J. Biomol. Screen. 2006. (11). 634–643.
8. Bendorf R., Boger R.H., Ergun S. et al. Angiotensin II type receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells // Circ. Res. 2003. (93). 438–447.
9. Drabarek B., Dymkowska D., Szczepanowska J. et al. TNFα affects energy metabolism and stimulates biogenesis of mitochondria in EA.hy926 endothelial cells // Int. J. Biochem. Cell Biol. 2012. (44). 1390–1397.
10. Gao H., Zhang J., Liu T. et al. Rapamycin prevents endothelial cell migration by inhibiting the endothelial-to-mesenchymal transition and matrix metalloproteinase-2 and -9: An in vitro study // Mol. Vis. 2011. (17). 3406–3414.
11. Keogh R.J. New technology for investigating trophoblast function // Placenta. 2010. (31). 347–350.
12. Kin K., Kasahara T., Ithon Y. et al. Cellular cooperation in lymphocyte activation // Clin. Exp. Immunol. 1979. (36). 292–298.
13. Lai Y., Liu X.H., Zhang Y. et al. Interleukin-8 induces the endothelial cell migration through the Rac 1/RhoA-p38MAPK pathway // Eur. Rev. Med. Pharmacol. Sci. 2012. (16). 630–638.
14. Lafontaine L., Chaudhry P., Lafleur M.J. et al. Transforming growth factor beta regulates proliferation and invasion of rat placental cell lines // Biol. Reprod. 2011. (84). 553–559.
15. Stein A., Knodler M., Makowski M. et al. Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction // BMC Cardiovasc. Disord. 2010. (10). 43–52.
About Authors (Correspondence):
Lykov A.P. – candidate of medical sciences, leading researcher laboratory of limphotropic therapy and limpodiagnostic, e-mail: lykovalex@freemail.ru
Poveshchenko O.V. – candidate of medical sciences, head of the laboratory of limphotropic therapy and limpodiagnostic, e-mail: poveschenkoov@yandex.ru
Bondarenko N.A. – postgraduate student laboratory of limphotropic therapy and limpodiagnostic, e-mail: bond802888@yandex.ru
Poveshchenko A.F. – doctor of medical sciences, head of the laboratory of physiology of the protective system, e-mail: poveshchenkoa200@mail.ru
Kim I.I. – researcher laboratory of limphotropic therapy and limpodiagnostic, e-mail: kii5@yandex.ru
Miller T.V. – postgraduate student laboratory of physiology of protective system, e-mail: tmw87@mail.ru
Pokushalov E.A. – doctor of medical sciences, vice-director, e-mail: cpsc@nricp.ru
Romanov A.B. – candidate of medical sciences, surgeon of the centre of surgically arrythmology, e-mail: aromanov1981@rambler.ru
Konenkov V.I. – doctor of medical sciences, academician of RAMS, director, e-mail: lymphology@soramn.ru
